289 related articles for article (PubMed ID: 30778125)
1. Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort.
Carbone T; Pafundi V; Tramontano G; Gilio M; Padula MC; Padula AA; D'Angelo S
Sci Rep; 2019 Feb; 9(1):2177. PubMed ID: 30778125
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases.
Shovman O; Gilburd B; Chayat C; Amital H; Langevitz P; Watad A; Guy A; Perez D; Azoulay D; Blank M; Segal Y; Bentow C; Mahler M; Shoenfeld Y
Clin Exp Rheumatol; 2018; 36(1):121-126. PubMed ID: 28770702
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan.
Hayashi N; Uto K; Imanishi A; Sugiyama D; Morinobu A; Saegusa J
Medicine (Baltimore); 2021 Mar; 100(9):e24556. PubMed ID: 33655922
[TBL] [Abstract][Full Text] [Related]
4. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
La Jeon Y; Kang SY; Lee WI; Kim MH
Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Relevance of Anti-DFS70 Autoantibodies.
Conrad K; Röber N; Andrade LE; Mahler M
Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
8. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls.
Schmeling H; Mahler M; Levy DM; Moore K; Stevens AM; Wick J; McMillan JD; Horneff G; Assassi S; Charles J; Salazar G; Mayes MD; Silverman ED; Klien-Gitelman M; Lee T; Brunner HI; Reed AM; Fritzler MJ
J Rheumatol; 2015 Dec; 42(12):2419-26. PubMed ID: 26472409
[TBL] [Abstract][Full Text] [Related]
10. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
12. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
Türkoğlu G; Berkem R; Karakoç AE
Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
[TBL] [Abstract][Full Text] [Related]
14. New genetically engineered DFS70 knock-out HEp-2 cells enable rapid and specific recognition of anti-DFS70 antibodies.
Bizzaro N; Fabris M
Autoimmunity; 2018 Jun; 51(4):152-156. PubMed ID: 29732925
[TBL] [Abstract][Full Text] [Related]
15. Assessing vitamin D levels in an anti-DFS70 positive population: New insights emerging.
Carbone T; Pafundi V; Bizzaro N; Infantino M; Padula MC; Padula AA; D'Angelo S
Autoimmunity; 2020 Jun; 53(4):231-236. PubMed ID: 32164458
[No Abstract] [Full Text] [Related]
16. Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases.
Aragón CC; Posso-Osorio I; Puerta G; González JD; Naranjo JC; Echeverri A; Ortíz E; Nieto-Aristizábal I; Barrera MC; Ríos-Serna LJ; Tobón GJ
Clin Rheumatol; 2020 Jul; 39(7):2163-2169. PubMed ID: 32086623
[TBL] [Abstract][Full Text] [Related]
17. High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA).
Seelig CA; Blüthner M; Seelig HP
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390377
[TBL] [Abstract][Full Text] [Related]
18. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
19. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.
Bentow C; Rosenblum R; Correia P; Karayev E; Karayev D; Williams D; Kulczycka J; Fritzler MJ; Mahler M
Lupus; 2016 Jul; 25(8):897-904. PubMed ID: 27252267
[TBL] [Abstract][Full Text] [Related]
20. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
Muro Y; Sugiura K; Morita Y; Tomita Y
Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]